The main focus of my research program is the quality of care received by patients with cancer especially in regards to delivery of systemic therapy. I am also interested in understanding the evolution and dissemination of findings from randomized controlled trials in cancer.
User-Centered Design of a Web-Based Tool to Support Management of Chemotherapy-Related Toxicities in Cancer Patients.
J Med Internet Res. 2019 Mar 28;21(3):e9958
Ambulatory Toxicity Management (AToM) Pilot: results of a pilot study of a pro-active, telephone-based intervention to improve toxicity management during chemotherapy for breast cancer.
Pilot Feasibility Stud. 2019;5:39
Usability Evaluation of a Mobile Phone-Based System for Remote Monitoring and Management of Chemotherapy-Related Side Effects in Cancer Patients: Mixed-Methods Study.
JMIR Cancer. 2018 Dec 21;4(2):e10932
J Oncol Pract. 2018 Dec;14(12):757-759
Hospitalisations and emergency department visits in cancer patients receiving systemic therapy: Systematic review and meta-analysis.
Eur J Cancer Care (Engl). 2018 Sep 20;:e12909
Psychooncology. 2018 Aug 13;:
Emergency department visits and unplanned hospitalizations in the treatment period for head and neck cancer patients treated with curative intent: A population-based analysis.
Oral Oncol. 2018 Aug;83:107-114
BMC Med Genomics. 2018 Aug 09;11(1):65
Health status, emergency department visits, and oncologists' feedback: An analysis of secondary endpoints from a randomized phase II geriatric assessment trial.
J Geriatr Oncol. 2018 Jul 21;:
Preventable Diabetic Complications After a Cancer Diagnosis in Patients With Diabetes: A Population-Based Cohort Study.
JNCI Cancer Spectr. 2018 Jan;2(1):pky008
Medical Oncologist, Princess Margaret Cancer Centre
Associate Professor of Medicine, University of Toronto
Clinical Lead, Quality Care and Access, Systemic Treatment Program, Cancer Care Ontario
Adjuct Scientist, Institute for Clinical Evaluative Sciences